Clinical and Molecular Hepatology (Clin Mol Hepatol, CMH)

Original Article

Cause of death and cause-specific mortality for primary liver cancer in South Korea: A nationwide population-based study in hepatitis B virus-endemic area

Bo Hyun Kim, Dahhay Lee, Kyu-Won Jung, Young-Joo Won, Hyunsoon Cho

Clin Mol Hepatol. 2022;28(2):242-253. Published online February 7, 2022

DOI: https://doi.org/10.3350/cmh.2021.0355

View: 5663 Download: 127 Web of Science: 14 Crossref: 13

Surgery versus radiofrequency ablation in patients with Child- Pugh class-A/single small (≤3 cm) hepatocellular carcinoma

Jungnam Lee, Young-Joo Jin, Seung Kak Shin, Jung Hyun Kwon, Sang Gyune Kim, Young Ju Suh, Yujin Jeong, Jung Hwan Yu, Jin-Woo Lee, Oh Sang Kwon, Soon Woo Nahm, Young Seok Kim

Clin Mol Hepatol. 2022;28(2):207-218. Published online November 24, 2021

DOI: https://doi.org/10.3350/cmh.2021.0294

View: 5672 Download: 217 Web of Science: 26 Crossref: 25

Editorial

Surgical resection versus ablation for early hepatocellular carcinoma: The debate is still open

Bo Hyun Kim

Clin Mol Hepatol. 2022;28(2):174-176. Published online January 26, 2022

DOI: https://doi.org/10.3350/cmh.2021.0400

View: 3962 Download: 112 Web of Science: 3 Crossref: 3

Review

The management of post-transplantation recurrence of hepatocellular carcinoma

Luckshi Rajendran, Tommy Ivanics, Marco PAW Claasen, Hala Muaddi, Gonzalo Sapisochin

Clin Mol Hepatol. 2022;28(1):1-16. Published online October 5, 2021

DOI: https://doi.org/10.3350/cmh.2021.0217

View: 8724 Download: 350 Web of Science: 32 Crossref: 35

Letter to the Editor

Impact of branched-chain amino acids and frailty on the management of lenvatinib-related fatigue in patients with hepatocellular carcinoma

Shigeo Shimose, Shunji Koya, Takumi Kawaguchi, Keisuke Hirota, Sachiyo Yoshio, Takashi Niizeki, Hiroo Matsuse, Takuji Torimura

Clin Mol Hepatol. 2021;27(4):616-619. Published online September 13, 2021

DOI: https://doi.org/10.3350/cmh.2021.0258

View: 5174 Download: 204 Web of Science: 3 Crossref: 3

Original Article

New next-generation microwave thermosphere ablation for small hepatocellular carcinoma

Hideyuki Tamai, Jumpei Okamura

Clin Mol Hepatol. 2021;27(4):564-574. Published online August 2, 2021

DOI: https://doi.org/10.3350/cmh.2021.0136

View: 5398 Download: 242 Web of Science: 16 Crossref: 16

Editorial

Can hepatocellular carcinoma recurrence be prevented after liver transplantation?

Jong Man Kim

Clin Mol Hepatol. 2021;27(4):562-563. Published online September 23, 2021

DOI: https://doi.org/10.3350/cmh.2021.0276

View: 4053 Download: 132 Web of Science: 2 Crossref: 2

Microwave thermosphere versus radiofrequency ablation for hepatocellular carcinoma: Are we approaching the time to end the debate?

Man-Deuk Kim

Clin Mol Hepatol. 2021;27(4):560-561. Published online September 8, 2021

DOI: https://doi.org/10.3350/cmh.2021.0279

View: 3920 Download: 128 Web of Science: 1 Crossref: 1

Snapshot

Hepatocellular carcinoma statistics in South Korea

Young Eun Chon, Soung Won Jeong, Dae Won Jun

Clin Mol Hepatol. 2021;27(3):512-514. Published online June 21, 2021

DOI: https://doi.org/10.3350/cmh.2021.0171

View: 6695 Download: 182 Web of Science: 25 Crossref: 26

Original Article

Serum fibrosis index-based risk score predicts hepatocellular carcinoma in untreated patients with chronic hepatitis B

Lilian Yan Liang, Hye Won Lee, Vincent Wai-Sun Wong, Terry Cheuk-Fung Yip, Yee-Kit Tse, Vicki Wing-Ki Hui, Grace Chung-Yan Lui, Henry Lik-Yuen Chan, Grace Lai-Hung Wong

Clin Mol Hepatol. 2021;27(3):499-509. Published online February 26, 2021

DOI: https://doi.org/10.3350/cmh.2020.0333

View: 5107 Download: 137 Web of Science: 14 Crossref: 14

Significant down-regulation of growth hormone receptor expression revealed as a new unfavorable prognostic factor in hepatitis C virus-related hepatocellular carcinoma

Ching-Chih Lin, Ta-Wei Liu, Ming-Lun Yeh, Yi-Shan Tsai, Pei-Chien Tsai, Chung-Feng Huang, Jee-Fu Huang, Wan-Long Chuang, Chia-Yen Dai, Ming-Lung Yu

Clin Mol Hepatol. 2021;27(2):313-328. Published online December 14, 2020

DOI: https://doi.org/10.3350/cmh.2020.0247

View: 11084 Download: 160 Web of Science: 9 Crossref: 7

Direct comparison of biopsy techniques for hepatic malignancies

Shang-Chin Huang, Ja-Der Liang, Shih-Jer Hsu, Tzu-Chan Hong, Hung-Chih Yang, Jia-Horng Kao

Clin Mol Hepatol. 2021;27(2):305-312. Published online December 3, 2020

DOI: https://doi.org/10.3350/cmh.2020.0301

View: 5123 Download: 163 Web of Science: 10 Crossref: 11

Negligible risks of hepatocellular carcinoma during biomarker-defined immune-tolerant phase for patients with chronic hepatitis B

Mi Young Jeon, Beom Kyung Kim, Jae Seung Lee, Hye Won Lee, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Kwang-Hyub Han, Seung Up Kim

Clin Mol Hepatol. 2021;27(2):295-304. Published online December 3, 2020

DOI: https://doi.org/10.3350/cmh.2020.0216

View: 5720 Download: 211 Web of Science: 17 Crossref: 21

Editorial

Biopsy or cytology for diagnosing hepatic focal lesions?

Haeryoung Kim

Clin Mol Hepatol. 2021;27(2):278-280. Published online March 4, 2021

DOI: https://doi.org/10.3350/cmh.2021.0031

View: 3765 Download: 79 Web of Science: 2 Crossref: 2

Negligible risk of hepatocellular carcinoma in chronic hepatitis B patients in immune-tolerant phase: Myth or fact

Terry Cheuk-Fung Yip, Grace Lai-Hung Wong, Vincent Wai-Sun Wong

Clin Mol Hepatol. 2021;27(2):273-277. Published online February 1, 2021

DOI: https://doi.org/10.3350/cmh.2021.0019

View: 4707 Download: 139 Web of Science: 5 Crossref: 6

Review

Optimizing the management of intermediate-stage hepatocellular carcinoma: Current trends and prospects

Takuji Torimura, Hideki Iwamoto

Clin Mol Hepatol. 2021;27(2):236-245. Published online December 3, 2020

DOI: https://doi.org/10.3350/cmh.2020.0204

View: 8894 Download: 390 Web of Science: 42 Crossref: 40

Original Article

Persistence of intrahepatic hepatitis B virus DNA integration in patients developing hepatocellular carcinoma after hepatitis B surface antigen seroclearance

Jeong Won Jang, Jin Seoub Kim, Hye Seon Kim, Kwon Yong Tak, Heechul Nam, Pil Soo Sung, Si Hyun Bae, Jong Young Choi, Seung Kew Yoon, Lewis R. Roberts

Clin Mol Hepatol. 2021;27(1):207-218. Published online December 3, 2020

DOI: https://doi.org/10.3350/cmh.2020.0115

View: 6989 Download: 258 Web of Science: 23 Crossref: 24

Obesity and the risk of primary liver cancer: A systematic review and meta-analysis

Won Sohn, Hyun Woong Lee, Sangheun Lee, Jin Hong Lim, Min Woo Lee, Chan Hyuk Park, Seung Kew Yoon

Clin Mol Hepatol. 2021;27(1):157-174. Published online November 26, 2020

DOI: https://doi.org/10.3350/cmh.2020.0176

View: 10236 Download: 412 Web of Science: 83 Crossref: 86

Radiation-induced abscopal effect and its enhancement by programmed cell death 1 blockade in the hepatocellular carcinoma: A murine model study

Gyu Sang Yoo, Won-Gyun Ahn, Shin-Yeong Kim, Wonseok Kang, Changhoon Choi, Hee Chul Park

Clin Mol Hepatol. 2021;27(1):144-156. Published online December 7, 2020

DOI: https://doi.org/10.3350/cmh.2020.0095

View: 7967 Download: 295 Web of Science: 22 Crossref: 22

Editorial

Exploring the mythical abscopal effect: Radiation and programmed cell death protein 1 (PD-1) blockade for hepatocellular carcinoma

Jun Won Kim, Ik Jae Lee

Clin Mol Hepatol. 2021;27(1):103-106. Published online December 14, 2020

DOI: https://doi.org/10.3350/cmh.2020.0297

View: 4152 Download: 98 Web of Science: 1 Crossref: 1

Metabolic disease as a risk of hepatocellular carcinoma

Naoshi Nishida

Clin Mol Hepatol. 2021;27(1):87-90. Published online December 3, 2020

DOI: https://doi.org/10.3350/cmh.2020.0302

View: 5093 Download: 111 Web of Science: 12 Crossref: 13

Special topic: Alcoholic liver diseases The 14th International Symposium on Alcoholic Liver and Pancreatic Diseases and Cirrhosis (ISALPDC)

Hepatic Hippo signaling inhibits development of hepatocellular carcinoma

Yuchen Liu, Xiaohui Wang, Yingzi Yang

Clin Mol Hepatol. 2020;26(4):742-750. Published online September 28, 2020

DOI: https://doi.org/10.3350/cmh.2020.0178

View: 8197 Download: 214 Web of Science: 41 Crossref: 40

Alcohol and hepatocarcinogenesis

Makiko Taniai

Clin Mol Hepatol. 2020;26(4):736-741. Published online October 1, 2020

DOI: https://doi.org/10.3350/cmh.2020.0203

View: 6753 Download: 188 Web of Science: 32 Crossref: 30

Autophagy and liver cancer

Xiaojuan Chao, Hui Qian, Shaogui Wang, Sam Fulte, Wen-Xing Ding

Clin Mol Hepatol. 2020;26(4):606-617. Published online October 1, 2020

DOI: https://doi.org/10.3350/cmh.2020.0169

View: 9029 Download: 262 Web of Science: 51 Crossref: 45

Letter to the Editor

How long should physicians follow up with patients after curative treatment for hepatocellular carcinoma?

Bo Hyun Kim

Clin Mol Hepatol. 2020;26(4):579-581. Published online September 23, 2020

DOI: https://doi.org/10.3350/cmh.2020.0200

View: 3882 Download: 76 Web of Science: 2 Crossref: 2

Phosphoinositide 3-kinase inhibitors are effective therapeutic drugs for the treatment of hepatocellular carcinoma?

Jeong Su Park, Soo Han Bae

Clin Mol Hepatol. 2020;26(4):577-578. Published online September 17, 2020

DOI: https://doi.org/10.3350/cmh.2020.0143

View: 3932 Download: 66 Web of Science: 1 Crossref: 1

Original Article

Inhibition of PI3K/Akt signaling suppresses epithelial-to-mesenchymal transition in hepatocellular carcinoma through the Snail/GSK-3/beta-catenin pathway

Seulki Lee, Eun Ji Choi, Eun Ju Cho, Yun Bin Lee, Jeong-Hoon Lee, Su Jong Yu, Jung-Hwan Yoon, Yoon Jun Kim

Clin Mol Hepatol. 2020;26(4):529-539. Published online August 24, 2020

DOI: https://doi.org/10.3350/cmh.2019.0056n

View: 8462 Download: 253 Web of Science: 31 Crossref: 31

Substantial risk of recurrence even after 5 recurrence-free years in early-stage hepatocellular carcinoma patients

Jihye Kim, Wonseok Kang, Dong Hyun Sinn, Geum-Youn Gwak, Yong-Han Paik, Moon Seok Choi, Joon Hyeok Lee, Kwang Cheol Koh, Seung Woon Paik

Clin Mol Hepatol. 2020;26(4):516-528. Published online September 11, 2020

DOI: https://doi.org/10.3350/cmh.2020.0016

View: 6669 Download: 213 Web of Science: 46 Crossref: 43

Stereotactic body radiation therapy for small (≤5 cm) hepatocellular carcinoma not amenable to curative treatment: Results of a single-arm, phase II clinical trial

Sang Min Yoon, So Yeon Kim, Young-Suk Lim, Kang Mo Kim, Ju Hyun Shim, Danbi Lee, Jihyun An, Jinhong Jung, Jong Hoon Kim, Han Chu Lee

Clin Mol Hepatol. 2020;26(4):506-515. Published online July 10, 2020

DOI: https://doi.org/10.3350/cmh.2020.0038

View: 7076 Download: 205 Web of Science: 48 Crossref: 52

The association of the serum levels of myostatin, follistatin, and interleukin-6 with sarcopenia, and their impacts on survival in patients with hepatocellular carcinoma

Kanghyug Choi, Hee Yoon Jang, Joong Mo Ahn, Sung Ho Hwang, Jung Wha Chung, Yun Suk Choi, Jin-Wook Kim, Eun Sun Jang, Gwang Hyeon Choi, Sook-Hyang Jeong

Clin Mol Hepatol. 2020;26(4):492-505. Published online July 10, 2020

DOI: https://doi.org/10.3350/cmh.2020.0005

View: 14123 Download: 311 Web of Science: 45 Crossref: 44

Viewed By 5835	Evaluating the therapeutic efficacy of NAD supplementation in management of metabolic dysfunction-associated steatotic liver disease: Key considerations
Viewed By 5262	2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Viewed By 4953	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Viewed By 4922	MAFLD: How is it different from NAFLD?
Viewed By 4557	Global incidence and prevalence of nonalcoholic fatty liver disease

Cited By 202	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Cited By 140	Global incidence and prevalence of nonalcoholic fatty liver disease
Cited By 119	2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Cited By 103	MAFLD: How is it different from NAFLD?
Cited By 93	Forecasted 2040 global prevalence of nonalcoholic fatty liver disease using hierarchical bayesian approach

Hepatic neoplasm